Summary
The effects of homatropine and atropine on plasma LH and prolactin (PRL) levels during the afternoon of pro-oestrus were investigated. Homatropine methylbromide was unable to block the spontaneous increase of LH but prevented the prolactin surge in pro-oestrous rats at doses of 450 and 700 mg/kg s.c. Atropine sulphate blocked both LH and PRL at doses of 450 and 700 mg/kg s.c. These two anticholinergics when injected into the 3rd ventricle (250μg/rat) blocked the pro-oestrus increase of LH and inhibited PRL. Pharmacological experiments were performed in parallel and the injection of either homatropine or atropine (450 mg/kg s.c.) resulted in the abolishment of peripheral toxic signs induced by pilocarpine (50 mg/kg s.c.) whereas its central toxic signs were prevented by atropine but not by homatropine.
Our findings suggest that the difference in action of systemic injections of atropine and homatropine on LH and PRL release is explained by a relatively low permeability of homatropine to the brain. Therefore, cholinergic LH-controlling mechanisms may be situated above the median eminence and those related to PRL placed outside the blood-brain barrier.
Similar content being viewed by others
References
Aarseth, P., andJ. A. B. Barstad: Blood-brain barrier permeability in various parts of the central nervous system. Arch. int. Pharmacodyn.176, 434–442 (1969).
Ankier, S. I., R. T. Brittain, andD. Jack: Investigation of central cholinergic mechanisms in the conscious mouse. Brit. J. Pharmacol.42, 127–136 (1971).
Aron, C., andG. Asch: Influence inhibitrice de l'atropine sur le déclenchement par le rapprochement sexuel, de la ponte ovulaire chez la Ratte mûre. C. R. Acad. Sci. (Paris)255, 3056 (1962).
Cramer andJ. C. Porter: Input to releasing factor cells. Progr. Brain Res.39, 73–84 (1973).
Dickey, R. P., andB. H. Marks: Adrenergic and cholinergic mechanisms in the regulation of gonadotrophin secretion in ovariectomized rats. Federation Proc.30, 253 (1971).
Donoso, A. O.: Chemical mediators and gonadotrophin secretion. Acta physiol. latinoam.23, 487–489 (1973).
Donoso, A. O., W. Bishop, P. Fawcett, L. Krulich, andS. M. McCann: Effects of drugs that modify brain monoamine concentrations on plasma gonadotropin and prolactin levels in the rat. Endocrinology89, 774 to 784 (1971).
Endrőczi, E., andJ. Hilliard: Luteinizing hormone releasing activity in different pools of rabbit and dog brain. Endocrinology77, 667–673 (1965).
Everett, J. W.: Neuroendocrine aspects of mammalian reproduction. Annu. Rev. Physiol.31, 383–416 (1969).
Everett, J. W., C. H. Sawyer, andJ. E. Markee: A neurogenic timing factor in control of the ovulating discharge of luteinizing hormone in the cyclic rat. Endocrinology44, 234–250 (1949).
Goodman, L. S., andA. Gilman: Drugs inhibiting the action of acetylcholine on structures innervated by postganglionic parasympathetic nerves. In: The pharmacological basis of therapeutics, pp. 524–548. New York: The Macmillan Co. 1970.
Kamberi, I. A., andE. S. Bacleon: Role of cholinergic synapses in neural circuits controlling the gonadotropin secretion. 55th Meeting Endocrine Society, proceed. A-136 (1973).
Kamberi, I. A., R. S. Mical, andJ. C. Porter: Effects of melatonin and serotonin on the release of FSH and prolactin. Endocrinology88, 1288 to 1293 (1971).
Lawson, D. M., andR. R. Gala: Plasma prolactin in ovariectomized estrogen-treated rats following systemic administration of several neurally active drugs. Federation Proc.33, 237 (1974).
Libertun, C., andS. M. McCann: Blockade of the release of gonadotropins and prolactin by subcutaneous or intraventricular injection of atropine in male and female rats. Endocrinology92, 1714–1724 (1973).
Lichtensteiger, W., andP. J. Keller: Tubero-infundibular dopamine neurons and the secretion of luteinizing hormone and prolactin: extrahypothalamic influences, interaction with cholinergic systems and the effect of urethane anesthesia. Brain Res.74, 279–303 (1974).
Lindström, L. H., andB. J. Meyerson: The effect of pilocarpine, oxotremorine and arecoline in combination with methylatropine or atropine on hormone activated oestrus behavior in ovariectomized rats. Psychopharmacologia Berl.11, 405–413 (1967).
Longo, V. G.: Behavioral and electroencephalographic effects of atropine and related compounds. Pharmacol. Rev.18, 965–996 (1966).
Monti, J. M., M. A. Sala, J. T. Otegui, W. L. Benedetti, andE. Griñó: Inhibition of ovarian compensatory hypertrophy by implants of atropine in the hypothalamus. Experientia26, 1263–1264 (1970).
Naftolin, F., K. Brown-Grant, andC. S. Corker: Plasma and pituitary luteinizing hormone and peripheral plasma oestradiol concentrations in the normal oestrous cycle of the rat and after experimental manipulation of the cycle. J. Endocrin.53, 17–30 (1972).
Sala, M. A.: Blockade of ovarian compensatory hypertrophy and ovulation in the rat by hypothalamic implants of an anticholinergic drug. J. neurovisc. Relat.32, 241–248 (1971).
Sawyer, C. H., B. V. Critchlow, andC. A. Barraclough: Mechanism of blockade of pituitary activation in the rat by morphine, atropine and barbiturates. Endocrinology57, 345–354 (1955).
Sawyer, C. H., J. E. Markee, andB. Townsend: Cholinergic and adrenergic components in the neurohumoral control of the release of LH in the rabbit. Endocrinology44, 18–37 (1949).
Schneider, H. P. G.: Kontinuierliche Messung von Plasma LH, FSH und Prolactin nach Gonadotropin-Releasern und Catecholaminpräkursoren. Acta endocrin., Kbh. Suppl.152, 3 (1972).
Shute, C. C. D., andP. R. Lewis: Cholinergic and monoaminergic pathways in the hypothalamus. Brit. med. Bull.22, 221–226 (1966).
Wuttke, W., andJ. Meites: Effects of ether and pentobarbital on serum prolactin and LH levels in proestrus rats. Proc. Soc. exp. Biol. (N.Y.)135, 648–652 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Donoso, A.O., Bacha, J.C. Role of the blood-brain barrier in the anticholinergic differential effects on LH and prolactin release in proestrous rats. J. Neural Transmission 37, 155–164 (1975). https://doi.org/10.1007/BF01663630
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01663630